Login / Signup

Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?"

Takumi Hasegawa
Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Keyphrases
  • adverse drug
  • healthcare
  • cross sectional
  • drug induced
  • emergency department
  • stem cells
  • clinical trial
  • bone marrow
  • mesenchymal stem cells